Chromosomal microarray analysis in a cohort of underrepresented population identifies SERINC2 as a novel candidate gene for autism spectrum disorder

Chromosomal microarray (CMA) is now recognized as the first-tier genetic test for detection of copy number variations (CNVs) in patients with autism spectrum disorder (ASD). The aims of this study were to identify known and novel ASD associated-CNVs and to evaluate the diagnostic yield of CMA in Tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Hnoonual, Areerat, Thammachote, Weerin, Tim-Aroon, Thipwimol, Rojnueangnit, Kitiwan, Hansakunachai, Tippawan, Sombuntham, Tasanawat, Roongpraiwan, Rawiwan, Worachotekamjorn, Juthamas, Chuthapisith, Jariya, Fucharoen, Suthat, Wattanasirichaigoon, Duangrurdee, Ruangdaraganon, Nichara, Limprasert, Pornprot, Jinawath, Natini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608768/
https://www.ncbi.nlm.nih.gov/pubmed/28935972
http://dx.doi.org/10.1038/s41598-017-12317-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608768/
https://www.ncbi.nlm.nih.gov/pubmed/28935972
http://dx.doi.org/10.1038/s41598-017-12317-3

Ejemplares similares